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Pharmaceuticals as environmental contaminants have received a lot of interest over 27 
the past decade but, for several pharmaceuticals, relatively little is known about their 28 
occurrence in European surface waters. Benzodiazepines, a class of pharmaceuticals 29 
with anxiolytic properties, have received interest due to their behavioral modifying 30 
effect on exposed biota. In this study, our results show the presence of one or more 31 
benzodiazepine(s) in 86% of the analyzed surface water samples (n=138) from 30 32 
rivers, representing seven larger European catchments. Of the 13 benzodiazepines 33 
included in the study, we detected 9, which together showed median and mean 34 
concentrations (of the results above limit of quantification) of 5.4 and 9.6 ng L-1, 35 
respectively. Four benzodiazepines (oxazepam, temazepam, clobazam, and 36 
bromazepam) were the most commonly detected. In particular, oxazepam had the 37 
highest frequency of detection (85%) and a maximum concentration of 61 ng L-1. 38 
Temazepam and clobazam were found in 26% (maximum concentration of 39 ng L-1) 39 
and 14% (maximum concentration of 11 ng L-1) of the samples analyzed, 40 
respectively. Finally, bromazepam was found only in Germany and in 16 out of total 41 
138 samples (12%), with a maximum concentration of 320 ng L-1. This study clearly 42 
shows that benzodiazepines are common micro-contaminants of the largest European 43 
river systems at ng L-1 levels. Although these concentrations are more than a 44 
magnitude lower than those reported to have effective effects on exposed biota, 45 
environmental effects cannot be excluded considering the possibility of additive and 46 
sub-lethal effects. 47 
 48 















Pharmaceutical residues in the environment are increasingly recognized as a major 50 
threat to aquatic ecosystems worldwide (Boxall et al., 2012). Several biochemically 51 
active pharmaceuticals have been found in aquatic systems globally, due to a 52 
combination of worldwide use and inadequate removing efficiency in sewage 53 
treatment plants (STPs) or a complete lack of STPs (Hughes et al., 2013; Verlicchi et 54 
al., 2012; Loos et al., 2013; Asimakopoulos and Kannan, 2016). One of the reasons 55 
behind the increased concern for pharmaceuticals in the environment is that even 56 
though pharmaceuticals are thoroughly investigated for toxicity in humans, studies on 57 
ecotoxicological and ecological effects of these potent and bioactive chemicals are 58 
severely underrepresented (Boxall et al., 2012). 59 
 60 
One group of pharmaceuticals that has acquired attention lately is that of 61 
benzodiazepines. Benzodiazepines, approximately 50 different active pharmaceutical 62 
ingredients on the global market, are anxiolytics, i.e. pharmaceuticals used to treat 63 
anxiety disorders. These pharmaceuticals are used frequently and globally, and 64 
because they are very persistent to degradation in STPs, they can be found at 65 
concentrations ranging from 0.01 to several µg L−1 in treated effluents (Calisto and 66 
Esteves, 2009; Kosjek et al., 2012; Verlicchi et al., 2012; Loos et al., 2013; Petrie et 67 
al., 2015, Asimakopoulos and Kannan, 2016). In surface waters, benzodiazepines 68 
have been found at concentrations ranging from 0.001 to 0.6 µg L−1;(Vulliet and 69 
Cren-Olivé, 2011; Hass et al,. 21012, Radovic et al., 2012; Brodin et al., 2013; 70 
Hughes et al., 2013; Valcarcel et al., 2013, Mendoza et al., 2014a; Miller et al., 2015; 71 
Racamonde et al., 2014a, 2014b Aminot et al., 2015; Arbelaez et al., 2015; Camilleri 72 
et al., 2015; Wu et al., 2015; Aminot et al., 2016). In addition, several 73 















persistence in aquatic environments (Boreen et al., 2003; Calisto et al., 2011) where 75 
they may remain in sediment deposits for decades (Klaminder et al 2015).  76 
 77 
Benzodiazepines potentiate the effect of gamma-aminobutyric acid (GABA) on 78 
GABA-A receptors, which produce increased inhibitory postsynaptic potentials 79 
through the GABA receptors’ chloride-linked channels (Sieghart, 1995; Sieghart et 80 
al., 2012). Benzodiazepines have a wide clinical use as anxiolytics, hypnotics, 81 
anticonvulsants, tranquilizers, and muscle relaxants, and have been in extensive use 82 
for half a century (Mohler et al., 2002, Lopez-Munoz et al., 2011). GABA receptors 83 
are evolutionary well preserved and can be found in a wide range of vertebrate 84 
species (Gunnarsson et al., 2008). It is therefore likely that aquatic organisms exposed 85 
to benzodiazepines can show a behavioral pharmacological response, which is not 86 
measurable with the current ecotoxicological standard methods (Klaminder et al., 87 
2014). For example, recent studies have shown that µg L-1 of the benzodiazepine 88 
oxazepam increased both activity and the feeding rate, while reduced sociality in 89 
exposed perch (Perca fluviatilis) (Brodin et al., 2013, 2014; Klaminder et al., 2014). 90 
 91 
The objective of this study was to investigate the occurrence of the most common 92 
benzodiazepines in European rivers, in order to obtain an overview on the presence of 93 
these pharmaceuticals in aqueous environments. Due to the large number of different 94 
benzodiazepines on the global market and the fact that several benzodiazepines also 95 
have active metabolites, a sub-set was selected. Selection was based on European sale 96 
statistics and potencies. An efficient and sensitive in-line liquid chromatography mass 97 















samples from six European catchments and 30 rivers and their tributaries were 99 
included in the study.  100 
 101 
2. Methods 102 
 103 
2.1. Chemicals 104 
All of the reference standards were classified as analytical grade (>98%) and 2H5-105 
oxazepam (Sigma-Aldrich, Steinheim, Germany) was used as internal standard. 106 
LC/MS grade quality of methanol and acetonitrile were purchased (Lichrosolv - 107 
hypergrade, Merck, Darmstadt, Germany) and the purified water was prepared using a 108 
Milli-Q Advantage, including an UV radiation source, ultrapure water system 109 
(Millipore, Billerica, USA). Formic acid (Sigma-Aldrich, Steinheim, Germany) was 110 
used to prepare the 0.1% mobile phases.  111 
 112 
2.2. Sample pretreatment and analytical method 113 
Water samples were filtered using 0.45 µm Filtropur S (Sarstedt, Nümbrecht, 114 
Germany) syringe filters and 5 ng of the internal standard 2H5-oxazepam were added 115 
to each sample (10 mL). Injection was based on an online solid phase extraction 116 
(SPE) system using two valves for column switching, which has been described 117 
previously (Khan et al., 2012). 1.0 mL was injected using a 1 mL loop, onto an online 118 
extraction column (OASIS HLB, 20 mm × 2.1 mm i.d., 15 µm particle size) and then 119 
onto an analytical column (Hypersil GOLD aQ, 50 mm × 2.1 mm i.d., 5 µm particles, 120 
Thermo Fisher Scientific, San Jose, CA, USA), following a corresponding guard 121 
column (20 mm × 2.1 mm i.d, 5 µm particles). The total analysis time of the online 122 
















2.3. Quality assurance and quality control 125 
Individual stock solutions of each benzodiazepine were prepared in methanol and 126 
stored at -18 °C. Two MS/MS transitions were used for positive identifications of 127 
analytes with the criterion that the ratio between the transitions was not allowed to 128 
deviate more than +/−30% from the ratio in the corresponding calibration standard. 129 
Retention times for all analytes also had to be within +/−2.5% of the retention time in 130 
the corresponding calibration standard. Together, this gave four identification points 131 
(the highest possible number), as described in the Commission Decision 2002/657/EC 132 
concerning the performance of analytical methods and the interpretation of results. 133 
Limit of quantification (LOQ) was determined from standard curves based on 134 
repeated measurements of low level spiked water (MilliQ and surface water), and the 135 
lowest point in the standard curve that had a signal/noise ratio of 10 was considered to 136 
be equal to the LOQ. A seven-point calibration curve over the range of 0.5–1000 ng 137 
L-1 was used for linearity evaluation and quantification. Carry-over effects were 138 
evaluated by injecting standards at 1000 ng L−1 followed by two mobile phase blanks. 139 
Every tenth sample in the analytical runs where either an instrumental or field blank. 140 
Precision tests, including the precision of extraction and the instrumental response, 141 
were conducted by performing multiple injections (n =10) of a 100 ng L-1 calibration 142 
standard. Matrix effects were evaluated by constructing standard addition calibration 143 
curves using surface water samples fortified to 0; 25; 125; and 250 ng L-1. The slopes 144 
of individual benzodiazepines standard addition curves, based on the areas for surface 145 
water samples, were compared to equivalent curves prepared based on results for 146 
Milli-Q samples. Detailed information about the validation parameters are shown in 147 
















2.4. Sampling, sample transport and storage 150 
A total of 138 samples were collected in 30 rivers and their tributaries; River Aire 151 
(n=13) and River Calder (n=11) in the UK, River Blanice and two tributaries (n=14) 152 
in the Czech Republic, Danube River and 15 tributaries (n=68) in Germany, Austria, 153 
Slovak Republic, Hungary, Croatia, Serbia, Romania and Bulgaria, one tributary to 154 
the River Ems in Germany (n=6), Rhine River and two tributaries (n=18) in Germany, 155 
River Tiber and one tributary (n=4) in Italy, and three tributaries (n=4) to the Weser 156 
River in Germany. Detailed information about the sampling sites and sampling dates 157 
are shown in Table S3, in supporting information.  158 
 159 
Aire and Calder River basin 160 
Total number of inhabitants in the Aire and Calder River basin (2,057 km2) is 161 
approximately 2.4 million people. Annual mean flow in the lowest part of the river is 162 
8.6 m3 s-1. 163 
 164 
Blanice River basin 165 
The Blanice river basin represents a typical midsized river basin in the Czech 166 
Republic. The total area of the basin is 860 km2 with length of the main stream of 93 167 
km and 12 relevant tributaries. Annual mean flow in the lowest part of the river is 4.6 168 
m3 s-1. Total number of inhabitants in the Blanice river basin is approximately 37,000 169 
(mean population density is 43 inhabitants km-2) and the biggest municipality is 170 
Prachatice (12,000 inhabitants), situated on Zivny stream (relevant tributary of the 171 
Blanice River). The outlet from STP Prachatice creates about 25% of total flow in the 172 
















Danube River basin 175 
The Danube is a river in central and Eastern Europe, which originates in the Black 176 
Forest of Germany and flows southeast to the Black Sea; it is the European Union's 177 
longest and the continent's second longest river (after the Volga). The Danube River 178 
Basin (801,463 km3) has a population of approximately 83 million people. Annual 179 
mean flow in the lowest part of the river is 6500 m3 s-1. 180 
 181 
Ems River basin 182 
Ems River is situated in Northwestern Germany and flows through North Rhine-183 
Westphalia and Lower Saxony, before discharging into Wadden Sea at Dollart Bay. 184 
Ems River basin (18,000 km2) has a population of approximately 3 million people. 185 
Annual mean flow in the lowest part of the river is 83 m3 s-1. 186 
 187 
Rhine River basin 188 
The Rhine River begins in the Swiss canton of Graubünden in the Southeastern Swiss 189 
Alps and flows into the North Sea. Rhine River basin (197,177 km2) has a population 190 
of approximately 50 million. The River Rhine is the second longest river in central 191 
and western Europe (after the Danube) and the busiest waterway in the world. 192 
Population density of the basin is approximately 250 inhabitants km-2, and all major 193 
cities in the region are situated on the Rhine or on its larger tributaries. Annual mean 194 
flow in the lower part of the river is 2300 m3 s-1. 195 
 196 















The Tiber River is the third longest river in Italy, rising from the Monte Fumaiolo in 198 
Emilia-Romagna and flowing 409 km through Toscana, Umbria and Lazio. In Rome 199 
it receives water from one of its main tributary, the river Aniene, then flows through 200 
Rome and finally enters the Thyrrenian sea in Fiumicino and in Ostia. The total 201 
human population in the Tiber River basin (17375 km2) is approximately 4.7 million 202 
people, giving a population density of approximately 270 inhabitants km-2. Annual 203 
mean flow in the lowest part of the river is 260 m3 s-1. 204 
 205 
Weser River basin 206 
The Weser River in Northwestern Germany flows through Lower Saxony, then 207 
reaching the Hanseatic-town Bremen, before emptying 50 km further North at 208 
Bremerhaven into the North Sea. Weser River basin (49,063 km2) is the fourth largest 209 
river basin in Germany and has a population of approximately 9.3 million people. 210 
Population density of the basin is approximately 190 inhabitants km-2. Annual mean 211 
flow in the lowest part of the river is 200 m3 s-1. 212 
 213 
Samplings was performed by taking grab samples (200 mL) 0.5 meter below the 214 
surface and please note that the results represent the specific moment when and where 215 
the samples were taken. Samples were collected into 500 mL pre-rinsed PET bottles 216 
and were kept frozen at −18 °C and shipped to Umeå University by fast courier. 217 
Samples were not thawed during transportation and the storage time for the samples 218 
did not exceed three months. Fortified surface water samples (100 ng L-1, n=10) were 219 
used to investigate the stability during three-month storage and the freeze-thaw cycle. 220 
 221 















Benzodiazepines were successfully determined in the water samples, with stable and 223 
reproducible results. No carry-over effects were observed, no benzodiazepines were 224 
detected in the instrumental or field blanks and R2 values were above 0.99 for all 225 
calibration curves in given concentration range (shown in Table S2 in supporting 226 
information). Matrix effects, i.e. the suppression or enhancement of analyte-ion 227 
signals due to co-eluting matrix components, are common in LC-MS/MS analysis. 228 
This effect is more pronounced in matrix-rich samples such as in influent and effluent 229 
samples compared to surface waters and only moderate effects (+/- 10%) were 230 
detected for the included benzodiazepines. Signal suppression was the most common 231 
matrix effect in this study. Limit of quantifications ranged from 0.5-5 ng L-1 (shown 232 
in Table S1 in supporting information) and <5% degradation was observed during 3 233 
months storage at -18 °C for all included benzodiazepines. 234 
 235 
One or more benzodiazepine(s) were determined in 86% of the analyzed samples 236 
(120/138) (Table S3). Measured levels were low; total median and mean 237 
concentrations of the results above LOQ were 5.4 and 9.6 ng L-1, respectively and 238 
four of the included benzodiazepines (clonazepam, chlordiazepoxide, halazepam, and 239 
lorazepam) were not detected in any samples. Four benzodiazepines (oxazepam, 240 
temazepam, clobazam, and bromazepam) were most predominantly found; oxazepam 241 
had the highest frequency of occurrence, it was measured in 85% of the samples 242 
(117/138) and had a maximum concentration of 61 ng L-1; temazepam was found in 243 
26% of the samples (36/138) and had a maximum concentration of 39 ng L-1; 244 
clobazam was found in 14% of the samples (19/138) and had a maximum 245 















and only in samples from Germany, and had a maximum concentration of 320 ng L-1 247 
(Table S4). 248 
 249 
3.1. Aire and Calder River basin 250 
Four of the target benzodiazepines were detected in the Aire and Calder Rivers, the 251 
highest concentrations were found for temazepam > oxazepam > diazepam > 252 
midazolam (Figure 1 and table S4). The total contributions of midazolam and 253 
diazepam were negligible, whilst temazepam and oxazepam represented 254 
approximately 70% and 30%, respectively. This correlates well with the fact that 255 
diazepam, temazepam, and oxazepam are all among the five most prescribed 256 
benzodiazepine in England (HSCIC, 2015). It should be noted that lorazepam is the 257 
second most prescribed benzodiazepine in England (HSCIC, 2015), but this 258 
benzodiazepine was not detect in either River Calder or Aire. None of the studied 259 
benzodiazepines were detected in the background samples CA1 or AI1. Midazolam 260 
was only detected in one sample from the River Aire and was not detected at all in the 261 
River Calder. Diazepam was detected in 8 of the 13 samples from the Aire, ranging 262 
from 0.3-1.7 ng L-1 and was not detected in the River Calder. The concentration trend 263 
in the River Aire shows that the major STPs of Esholt and Leeds are sources of 264 
diazepam, although there was also a significant contribution from the small STP at 265 
Byram (population served approximately 45,000). Diazepam concentrations decrease 266 
rapidly after peaks, which indicate rapid degradation or sorption to sediments 267 
(Loeffler et al, 2005), since dilution alone cannot explain the decrease. Both 268 
oxazepam and temazepam are degradation products from diazepam, which increases 269 
the complexity of the results somewhat. Oxazepam and temazepam were detected in 270 















concentration trends.  272 
 273 
Our results show that all benzodiazepines are being released from the same sources 274 
and their concentrations are linked to population density. For each of these 275 
benzodiazepines, very clear concentration increases are observed after the major STPs 276 
on each river. Maximum concentrations of oxazepam and temazepam, at 28 and 67 ng 277 
L-1, respectively, were observed on the River Aire downstream of Leeds STP, which 278 
is the largest on the river. The concentration profiles in the River Calder are relatively 279 
flat in comparison to the River Aire. Most notable is the significant increase after 280 
Halifax STP (21 km), serving a population of 100,000, the third largest STP on the 281 
river. Concentrations of oxazepam and temazepam peaked here at 14 and 38 ng L-1, 282 
respectively. Halifax STP is in close proximity to Calderdale Royal Hospital, and it is 283 
likely that benzodiazepine prescription in this area is relatively high. The river flow at 284 
Halifax is approximately one third of the final discharge, meaning a significant 285 
concentration increase could be achieved by a relatively small mass input to the river. 286 
After Halifax, several smaller concentration peaks were observed after nearly every 287 
STP until they peak again just before the confluence with the River Aire. Only 288 
oxazepam surpasses the Halifax concentration at the pre-confluence location.  289 
 290 
3.2. Blanice River basin 291 
A total of 14 surface water samples were collected and analyzed in the Blanice River 292 
basin (Figure 2 and table S4). Six benzodiazepines were determined in these samples, 293 
but only oxazepam was found with significantly important frequency, i.e. in 10 of 14 294 
samples collected in the middle and downstream part of the Blanice River and its 295 















Prachatice (site BL 5; 19 ng L-1) and in the sites situated at lower parts of Blanice 297 
River (sites BL 13, BL 14; 20 ng L-1, 17 ng L-1, respectively). The highest number of 298 
benzodiazepines (diazepam, midazolam, oxazepam, prazepam, and temazepam) was 299 
found at the site BL 13 situated on Blanice River upstream of Vodnany. The main 300 
sources of the site contamination are probably smaller municipalities (Bavorov, 301 
Svinetice) situated a few kilometers upstream of the BL 13 site where treatment of 302 
municipal wastewater is poor. Nevertheless, the presence of prazepam and 303 
temazepam in surface water is a bit surprising as neither is registered for human 304 
medical purposes in Czech Republic. The main benzodiazepines prescribed in Czech 305 
Republic are (in falling order) alprazolam, diazepam, bromazepam, and clonazepam 306 
(based on daily defined dose, DDD per 1,000 inhabitants and day) (SUKL, 2010).  307 
 308 
3.3. Danube River basin 309 
In the Danube River and its tributaries eight benzodiazepines were found (alprazolam, 310 
clobazam, diazepam, flunitrazepam, midazolam, oxazepam, prazepam, and 311 
temazepam; Figure 3 and table S4). The two most relevant compounds were 312 
oxazepam and clobazam with occurrence frequencies of 85 and 31%, respectively. 313 
The maximum concentration found for oxazepam was 15 ng L-1, in sample DA10 314 
(Wildungsmauer, Austria), and for clobazam 11 ng L-1 in sample DA2 (Kelheim – 315 
gauging station, Germany). The mean and median concentrations for these two most 316 
relevant benzodiazepines in the Danube River and its tributaries were 5.9 and 5.4 ng 317 
L-1 for oxazepam, and 5.8 and 5.0 ng L-1 for clobazam (statistics considering only the 318 
results > LOQ). Temazepam was present in 19% of the samples, prazepam in 10%, 319 
midazolam in 9%, alprazolam in 6%, flunitrazepam in 4%, and diazepam in 3%, with 320 















L-1 for midazolam, 1.6 ng L-1 for alprazolam, 2.0 ng L-1 for flunitrazepam, and 2.3 ng 322 
L-1 for diazepam. 323 
 324 
3.4. Ems River basin 325 
Only the tributary Hase River was included in this study and four benzodiazepines 326 
were found (bromazepam, diazepam, oxazepam, and temazepam; Figure 4 and table 327 
S4). Main benzodiazepines prescribed in Germany are (in falling order) lorazepam, 328 
diazepam, bromazepam, oxazepam and alprazolam (based on DDD per 1,000 329 
inhabitants and day) (Arzneiverordnungsreport, 2013). Two compounds had 330 
occurrence frequencies of 100 %, oxazepam and bromazepam; the maximum 331 
concentration detected for oxazepam was 37 ng L-1 in sample EM2 (upstream of 332 
Quackenbrück) and for bromazepam 150 ng L-1 in sample EM1 and EM3 (both 333 
around Quackenbrück). In addition, diazepam was found in 50% of the samples and 334 
temazepam in 33%, with maximum concentrations 2.3 ng L-1 for diazepam and 14 ng 335 
L-1 for temazepam. It should be noted that no lorazepam was found, despite that this 336 
was the most prescribed benzodiazepine in Germany, which indicates that this 337 
compound has a short half-life in surface waters. 338 
 339 
3.5. Rhine River basin 340 
In the Rhine River and its tributaries, six benzodiazepines were found (alprazolam, 341 
bromazepam, diazepam, flunitrazepam, oxazepam, and temazepam; Figure 4 and 342 
table S4), which all are among the most prescribed benzodiazepines in Germany 343 
(Arzneiverordnungsreport, 2013). The two most common compounds were oxazepam 344 
and bromazepam with occurrence frequencies of 100% and 50%, respectively. The 345 















(downstream Witten) and for bromazepam 91 ng L-1 in sample RH13 (upstream of 347 
Witten). Two samples were taken in the River Rhine (RH1, 2) directly downstream 348 
Cologne and oxazepam and bromazepam were detected at both sites. In the two 349 
tributaries Wupper (RH3-9) and Ruhr River (RH10-18), concentration increases were 350 
observed after the major STPs on each river. Highest concentrations of 351 
benzodiazepines, 77 ng L-1 bromazepam and 26 ng L-1 oxazepam, were measured in 352 
the Wupper River at site RH9 which is located 4.2 km downstream of the 353 
Buchenhofen STP, the largest STP in the Wuppertal region. Highest concentrations in 354 
the Ruhr River, 30-91 ng L-1 of bromazepam and 36-61 ng L-1 of oxazepam, were 355 
measured at sites RH11-14, which are located on a stretch of the river that receives 356 
effluent from 5 major STPs, including STP Hagen. Other benzodiazepines found were 357 
diazepam (in 50% of the samples), temazepam (25%), flunitrazepam (11%), and 358 
alprazolam (3.6%), with maximum concentrations of 2.8 ng L-1 for diazepam, 17 ng 359 
L-1 for temazepam, 2.0 ng L-1 for flunitrazepam, and 1.6 ng L-1 for alprazolam.  360 
 361 
3.6. Tiber River basin 362 
The first sampling point was a pristine stretch of River Tiber at the source of the river 363 
(TI1); the second sampling site was characterized by agricultural impact (TI2); the 364 
third sampling point was at the tributary Aniene (TI3), a stream that suffers from 365 
municipal and industrial discharges; the fourth sampling site was an urban impacted 366 
area of Tiber River after the city Rome, close to the mouth of the river (TI4) (Figure 5 367 
and table S4). In the Tiber River, only oxazepam was found in the two urban 368 
impacted samples TI3 and 4; the concentrations were low: 1.4 ng L-1 in TI3 and 2.3 369 
















3.7. Weser River basin 372 
Only tributaries to the Weser River were included in this study and four 373 
benzodiazepines were found (bromazepam, diazepam, flunitrazepam and oxazepam; 374 
see Figure 4 and table S4), which all are among the most prescribed benzodiazepines 375 
in Germany (Arzneiverordnungsreport, 2013). The two compounds with highest 376 
occurrence frequencies were oxazepam and diazepam with of 100% and 50%, 377 
respectively. The maximum concentration detected for oxazepam was 16 ng L-1 and 378 
for diazepam 1.0 ng L-1, both in sample WE1 (Wehrder Kanal). In addition, 379 
bromazepam and flunitrazepam were found in 25% of the samples, with maximum 380 
concentrations 320 ng L-1 for bromazepam and 2.0 ng L-1 for flunitrazepam. 381 
 382 
3.8. General discussion 383 
This screening study on benzodiazepines in European rivers provides important 384 
information that can be used in environmental risk assessments of these 385 
pharmaceuticals. Detected levels corresponds to earlier studies with oxazepam and 386 
temazepam being the benzodiazepines detected in highest concentration in surface 387 
waters in Europe, e.g. oxazepam levels were in the range 21-210 ng L-1 (Aminot et 388 
al., 2015) and 9-310 ng L-1 (Camilleri et al., 2015) in France, 2-50 ng L-1 (Valcarcel et 389 
al., 2013) in Spain and 30-40 ng L-1 (Hass et al., 2012) in Germany. Detected levels of 390 
diazepam also correspond well with previous reported concentrations of below LOQ 391 
or low ng L-1 levels in Germany (Hass et al., 2012), France (Aminot et al., 2015) and 392 
Spain (Mendoza et al., 2014b; Valcarcel et al., 2013). Bromazepam levels were 393 
considerably higher than levels reported in France (Aminot et al., 2015), but this 394 
could partially be explained by the distance between sampling sites and STPs, 395 















only a few exceptions. No lorazepam was detected in this study despite the fact it is 397 
one of the most prescribed benzodiazepines in both Germany and the UK and 398 
previous studies have shown levels of low ng L-1 levels (Vulliet and Cren-Olivé, 399 
2011) and in the range of 6-25 ng L-1 in France, 1.6-37 ng L-1 (Camilleri et al., 2015) 400 
and 34-149 ng L-1 (Mendoza et al., 2014b) in Spain, and at 34 ng L-1 in one sampling 401 
point in the Danube (Radovic et al., 2012). No degradation of lorazepam was 402 
observed during three-month storage at -18 °C and LOQ of methods used are 403 
comparable to these previous studies. Extremely high concentrations of lorazepam 404 
have been detected in wastewater in Spain, e.g. a mean of ca 10 µg L−1 in influent and 405 
700 ng L−1 in effluent, which the authors   explained with the use of this 406 
pharmaceutical in stockbreeding in the region (Esteban et al., 2012). Our results 407 
indicate that smaller- to medium-sized rivers in highly populated regions, e.g. River 408 
Aire, Blanice River, and Ruhr River, have concentrations of benzodiazepines that are 409 
directly influenced by effluent from STPs. In comparison, the results from the Danube 410 
River show that this large river system has lower and more consistent levels of 411 
benzodiazepines. Hence, smaller rivers tend to show higher peak concentrations that 412 
vary spatially, while larger rivers show less variability and overall lower 413 
concentrations. No benzodiazepines were detected at the seven pristine sampling 414 
locations included in our study (AI1, CA1, BL1-2, 4, 8 and TI1), which are not 415 
influenced by wastewater effluent (Table S4).  416 
 417 
This study clearly shows that many benzodiazepines are present in European surface 418 
waters at ng L-1 levels, and that benzodiazepine concentrations can reach 419 
concentrations (200 ng L-1) at which effects on gene expressions in fish has been 420 















µg L-1 levels of benzodiazepines (Brodin et al., 2013, 2014; Klaminder et al., 2014, 422 
Huerta et al., 2016), i.e. levels an order of magnitude or more higher than the 423 
concentrations detected in this study, but concentrations that could still be relevant 424 
considering additive effects. 425 
 426 
4. Conclusion 427 
In this study we measured 13 benzodiazepines in 138 water samples from six 428 
European river basins and 30 rivers and their tributaries.  429 
• One or more benzodiazepine(s) were present in 120 (86%) of the 138 samples 430 
with total median and mean concentrations of the results above LOQ of 5.4 431 
and 9.6 ng L-1. 432 
• Four benzodiazepines (oxazepam, temazepam, clobazam, and bromazepam) 433 
were most predominantly found with a frequency of occurrence of 85%, 26%, 434 
14%, and 12%, respectively. 435 
• Maximum concentrations measured for oxazepam, temazepam, clobazam, and 436 
bromazepam were 61 ng L-1, 39 ng L-1, 11 ng L-1, and 320 ng L-1, respectively. 437 
• This study clearly shows that there are several benzodiazepines present in 438 
European surface waters at low ng L-1 levels, and although levels are 439 
significantly lower than those that have been shown to have effect on exposed 440 
biota, environmental effects cannot be dismissed. 441 
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Figure 1. Sampling locations and measured levels of benzodiazepines in UK; A1-13 River 
Aire, CA1-11 River Calder. Exact positions of the sampling sites and sampling dates are 
presented in table S1 and all measured values are presented in table S2. 
 
Figure 2. Sampling locations and measured levels of benzodiazepines in the Czech Republic; 
BL1-3, 7, 11-14 Blanice River, BL4-6 Zivny Stream, BL8-10 Libotynsky Stream. Exact 
positions of the sampling sites and sampling dates are presented in table S1 and all measured 
values are presented in table S2. 
 
Figure 3. Sampling locations and measured levels of benzodiazepines in the Danube River 
basin; DA1-11,13-15, 17, 19-22, 24-28, 30-34, 36, 38-40, 42-47, 49, 50,52, 53, 55, 57, 59-62, 
65-68 Danube River, DA12 Morava River, DA16 Moson River, DA18 Vah River, DA23 
Rackeve-Soroksar River, DA29 Drava River, DA35 Tisa River, DA37 Sava River, DA41 
Velika Morava River, DA48 Timok River, DA51 Iskar River, DA54 Jantra River, DA56 
Russenski Lom River, DA58 Arges River, DA63 Siret River, DA64 Prut River. Exact 
positions of the sampling sites and sampling dates are presented in table S1 and all measured 
values are presented in table S2. 
 
Figure 4. Sampling locations and measured levels of benzodiazepines in Germany; EM1-6 
Hase River, RH 1, 2 River Rhine, RH3-9 Wupper River, RH10-18 Ruhr River, WE1 Hunte 
River, WE2 Wehrder canal WE3, 4 River Geeste. Exact positions of the sampling sites and 















Figure 5. Sampling locations and measured levels of benzodiazepines in Italy; TI1,2,4 River 
Tiber, TI3 Aniene River. Exact positions of the sampling sites and sampling dates are 





















Figure 1. Sampling locations and measured levels of benzodiazepines in UK; A1-13 River Aire, CA1-11 River Calder.  
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Figure 2. Sampling locations and measured levels of benzodiazepines in the Czech Republic; BL1-3, 7,  
11-14 Blanice River, BL4-6 Zivny Stream, BL8-10 Libotynsky Stream. Exact positions of the sampling  















Figure 3. Sampling locations and measured levels of benzodiazepines in the Danube River basin; DA1-11,13-15, 17, 19-22, 24-28,  
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Figure 4. Sampling locations and measured levels of benzodiazepines in Germany; EM1-6 
Hase River, RH 1, 2 River Rhine, RH3-9 Wupper River, RH10-18 Ruhr River, WE1 Hunte 
River, WE2 Wehrder canal WE3, 4 River Geeste. Exact positions of the sampling sites and 















Figure 5. Sampling locations and measured levels of benzodiazepines in Italy; TI1,2,4 River 
Tiber, TI3 Aniene River. Exact positions of the sampling sites and sampling dates are 













• We have developed an analytical method to measure 13 benzodiazepines at 
environmental relevant concentrations 
• We have measured 138 water samples from six European river basins and 31 rivers 
and their tributaries.  
• This study clearly shows that there are several benzodiazepines present in European 
surface waters at ng L-1 levels 
 
